A 46−year−old woman underwent a cada− veric renal transplant. Three months later, she developed diarrhoea, fresh rectal bleeding, and cervical lymphadenopathy. Renal biopsy showed no evidence of re− jection. Flexible sigmoidoscopy revealed multiple colonic ulcers, with no active bleeding ( Figure 1 ). Biopsies showed post−transplant lymphoproliferative dis− order (PTLD). The cells were positive for Epstein±Barr virus (EBV) latent mem− brane protein, and positive for CD20, CD23, Pax 5, and EBV DNA. Tacrolimus (Astellaf Pharma, Ireland) was discontin− ued and anti−CD20 antibody treatment (rituximab; Roche, Basle, Switzerland) was started.
However, 3 weeks later, another episode of rectal bleeding occurred. Flexible sig− moidoscopy showed necrotic, sloughy mucosa, with bleeding from multiple co− lonic ulcers ( Figure 2 ). An emergency lap− arotomy revealed numerous vasculitic areas on serosal surfaces in the small and large bowel, corresponding to sites of bowel ulceration. Subtotal colectomy with end ileostomy was carried out. His− topathological analysis of the specimen confirmed EBV−associated PTLD. Despite continued anti−CD20 therapy, and inotro− pic/ventilatory support in the intensive− care unit, the patient died 14 days post− operatively.
PTLD is a complication of immunosup− pression following organ transplantation. Eighty percent of cases are associated with EBV [1] . Following renal transplanta− tion in adults, the incidence of PTLD is 0.5 ± 2.0 % [2] . The time of onset depends on the organ transplanted and on the type and duration of immunosuppres− sion; with tacrolimus, the mean is 4 months [2] . Gastrointestinal tract invol− vement occurs in up to 20 % of cases of PTLD, due to the presence of mucosa− associated lymphoid tissue [3] . The distal small bowel is most commonly affected [4] . Reducing immunosuppression (the risk of graft rejection should be consid− ered), if successful, usually results in im− provement within 2 ± 4 weeks. If this fails, a high mortality rate of 50 ± 90 % is report− ed [1] . Anti−B−cell antibodies can be used.
In conclusion, rectal bleeding and isolated gastrointestinal PTLD, as in this case, are uncommon [5] , but should be considered in post−transplant patients. The condition can be aggressive and fatal despite treat− ment. Early endoscopy with biopsies for even mild nonspecific symptoms of PTLD is therefore advised. 
